Keywords: insmed, shares, soar, news, od, designation, iplex

Insmed shares soar on news of US OD designation for Iplex

Article | 19 December 2005

Print This

US drugmaker Insmed Inc says that the Food and Drug Administration has approved Iplex (mecasermin rinfabate (rDNA origin) injection) for ...

Enjoying this article? To continue reading you need to login or subscribe.

Subscribe now
for unlimited access to all articles

Subscriptions are £60 per month, pay as you go.
Find out more details.

Already a subscriber? Click here to log in